141 related articles for article (PubMed ID: 24742710)
1. Utilization of Rad51C promoter for transcriptional targeting of cancer cells.
Cao Y; Xu Y; Zhang L; Li Z; Jiang Y; Tian X; Seluanov A; Gorbunova V; Mao Z
Oncotarget; 2014 Apr; 5(7):1805-11. PubMed ID: 24742710
[TBL] [Abstract][Full Text] [Related]
2. Use of the XRCC2 promoter for in vivo cancer diagnosis and therapy.
Chen Y; Li Z; Xu Z; Tang H; Guo W; Sun X; Zhang W; Zhang J; Wan X; Jiang Y; Mao Z
Cell Death Dis; 2018 Apr; 9(4):420. PubMed ID: 29549248
[TBL] [Abstract][Full Text] [Related]
3. Use of the Rad51 promoter for targeted anti-cancer therapy.
Hine CM; Seluanov A; Gorbunova V
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20810-5. PubMed ID: 19106292
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells.
Liu N; Schild D; Thelen MP; Thompson LH
Nucleic Acids Res; 2002 Feb; 30(4):1009-15. PubMed ID: 11842113
[TBL] [Abstract][Full Text] [Related]
5. Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells.
Wiese C; Collins DW; Albala JS; Thompson LH; Kronenberg A; Schild D
Nucleic Acids Res; 2002 Feb; 30(4):1001-8. PubMed ID: 11842112
[TBL] [Abstract][Full Text] [Related]
6. RAD51C interacts with RAD51B and is central to a larger protein complex in vivo exclusive of RAD51.
Miller KA; Yoshikawa DM; McConnell IR; Clark R; Schild D; Albala JS
J Biol Chem; 2002 Mar; 277(10):8406-11. PubMed ID: 11744692
[TBL] [Abstract][Full Text] [Related]
7. Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway.
Chun J; Buechelmaier ES; Powell SN
Mol Cell Biol; 2013 Jan; 33(2):387-95. PubMed ID: 23149936
[TBL] [Abstract][Full Text] [Related]
8. Complex formation by the human Rad51B and Rad51C DNA repair proteins and their activities in vitro.
Lio YC; Mazin AV; Kowalczykowski SC; Chen DJ
J Biol Chem; 2003 Jan; 278(4):2469-78. PubMed ID: 12427746
[TBL] [Abstract][Full Text] [Related]
9. A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin.
Connell PP; Siddiqui N; Hoffman S; Kuang A; Khatipov EA; Weichselbaum RR; Bishop DK
Cancer Res; 2004 May; 64(9):3002-5. PubMed ID: 15126333
[TBL] [Abstract][Full Text] [Related]
10. Human Rad51C deficiency destabilizes XRCC3, impairs recombination, and radiosensitizes S/G2-phase cells.
Lio YC; Schild D; Brenneman MA; Redpath JL; Chen DJ
J Biol Chem; 2004 Oct; 279(40):42313-20. PubMed ID: 15292210
[TBL] [Abstract][Full Text] [Related]
11. Evidence for simultaneous protein interactions between human Rad51 paralogs.
Schild D; Lio YC; Collins DW; Tsomondo T; Chen DJ
J Biol Chem; 2000 Jun; 275(22):16443-9. PubMed ID: 10749867
[TBL] [Abstract][Full Text] [Related]
12. Nuclear localization of Rad51B is independent of Rad51C and BRCA2.
Miller KA; Hinz JM; Yamada NA; Thompson LH; Albala JS
Mutagenesis; 2005 Jan; 20(1):57-63. PubMed ID: 15701685
[TBL] [Abstract][Full Text] [Related]
13. Interplay between human DNA repair proteins at a unique double-strand break in vivo.
Rodrigue A; Lafrance M; Gauthier MC; McDonald D; Hendzel M; West SC; Jasin M; Masson JY
EMBO J; 2006 Jan; 25(1):222-31. PubMed ID: 16395335
[TBL] [Abstract][Full Text] [Related]
14. The Arabidopsis RAD51 paralogs RAD51B, RAD51D and XRCC2 play partially redundant roles in somatic DNA repair and gene regulation.
Wang Y; Xiao R; Wang H; Cheng Z; Li W; Zhu G; Wang Y; Ma H
New Phytol; 2014 Jan; 201(1):292-304. PubMed ID: 24102485
[TBL] [Abstract][Full Text] [Related]
15. Mediator function of the human Rad51B-Rad51C complex in Rad51/RPA-catalyzed DNA strand exchange.
Sigurdsson S; Van Komen S; Bussen W; Schild D; Albala JS; Sung P
Genes Dev; 2001 Dec; 15(24):3308-18. PubMed ID: 11751636
[TBL] [Abstract][Full Text] [Related]
16. Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.
Hine CM; Seluanov A; Gorbunova V
Mol Ther; 2012 Feb; 20(2):347-55. PubMed ID: 22008909
[TBL] [Abstract][Full Text] [Related]
17. In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines.
Lidor YJ; Lee WE; Nilson JH; Maxwell IH; Su LJ; Brand E; Glode LM
Am J Obstet Gynecol; 1997 Sep; 177(3):579-85. PubMed ID: 9322627
[TBL] [Abstract][Full Text] [Related]
18. Split dose recovery studies using homologous recombination deficient gene knockout chicken B lymphocyte cells.
Rao BS; Tano K; Takeda S; Utsumi H
J Radiat Res; 2007 Jan; 48(1):77-85. PubMed ID: 17229998
[TBL] [Abstract][Full Text] [Related]
19. Germline mutation in the RAD51B gene confers predisposition to breast cancer.
Golmard L; Caux-Moncoutier V; Davy G; Al Ageeli E; Poirot B; Tirapo C; Michaux D; Barbaroux C; d'Enghien CD; Nicolas A; Castéra L; Sastre-Garau X; Stern MH; Houdayer C; Stoppa-Lyonnet D
BMC Cancer; 2013 Oct; 13():484. PubMed ID: 24139550
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a synthetic beta-catenin-dependent promoter for tumor-specific cancer gene therapy.
Lipinski KS; Djeha HA; Gawn J; Cliffe S; Maitland NJ; Palmer DH; Mountain A; Irvine AS; Wrighton CJ
Mol Ther; 2004 Jul; 10(1):150-61. PubMed ID: 15233950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
